In this episode, our guest is Lewis Bender, Chairman, and CEO, of Intensity Therapeutics’ Founder which is a late-stage clinical biotechnology company whose mission is to help patients live longer, higher quality lives by discovering, developing, and commercializing first-in-class cancer drugs that attenuate tumors with minimal side effects, while training the patient’s immune system to fight the cancer.  The Company’s lead product candidate, INT230-6, is currently in human clinical studies to treat refractory solid tumors.

Talking points:
Milestone Achievement: "Congratulations on dosing the first patient in the INVINCIBLE-4 Phase 2 clinical trial for triple-negative breast cancer. Can you walk us through the significance of this milestone and what it means for the future of Intensity Therapeutics?"

Innovative Approach of INT230-6: "Intensity Therapeutics focuses on developing cancer treatments that not only attenuate tumors with minimal side effects but also train the immune system to fight cancer. Could you explain how your lead product, INT230-6, achieves this unique approach and what differentiates it from existing cancer therapies?"

Collaboration with SAKK: "Your partnership with The Swiss Group for Clinical Cancer Research (SAKK) is a key component of the INVINCIBLE-4 study. How does this collaboration enhance your clinical development efforts, and what are you hoping to achieve together in this trial?"

Impact on Triple-Negative Breast Cancer (TNBC): "Triple-negative breast cancer is known for being particularly aggressive and having limited treatment options. How does INT230-6 address the unmet needs of TNBC patients, and what potential impact do you foresee it having on improving patient outcomes?"

Future Vision and Next Steps: "Looking ahead, what are the next steps for Intensity Therapeutics following the initiation of the INVINCIBLE-4 study? How do you envision the future of your company in the evolving landscape of cancer therapeutics?"

Guest - Lewis Bender

Host - Hillary Blackburn, PharmD, MBA

• https://www.linkedin.com/in/hillary-blackburn-67a92421/ 
• @talktoyourpharmacist for Instagram and Facebook

In this episode, our guest is Tom Campbell, the Dean and Associate Professor of Pharmacy Practice at Lipscomb University College of Pharmacy in Nashville. Dr. Campbell received his Pharm.D. degree from the University of Tennessee College of Pharmacy and received board certification in pharmacotherapy in 1995. His prior work experience includes a pharmacy practice residency with VA Medical Center in Memphis, Columbus Regional Health System in Columbus, Georgia, and Sanofi Pharmaceuticals. He also served as Clinical Assistant Professor at Auburn University. Dr. Campbell has served as President of the Tennessee Pharmacists Association and served on the Board of Directors. He is a member of AACP, ASHP, APhA, CPFI and TPA. He's a recipient of the 2024 APhA Academy of Student Pharmacists Outstanding Dean Award which was established to recognize a school or college of pharmacy dean who has made significant contributions to the APhA-ASP Chapter and promoted with distinction the welfare of student pharmacists through various community service, leadership and professional activities. 

Dr. Campbell is a Sunday school teacher and former elder at the Spring Meadows Church of Christ in Spring Hill, TN. He has traveled to Central America as part of medical mission campaigns numerous times. Dr. Campbell and his late wife, Susan, have three sons.

During the discussion, we explored questions around:

• How faith influences our daily work in healthcare
• The ways faith impacts health behaviors and decision-making
• The role faith plays in job satisfaction and professional fulfillment

It was inspiring to engage in meaningful dialogue with a leader who also sees their work as a calling to serve others. I'm grateful to Dean Campbell at Lipscomb University for fostering conversations that remind us of the deeper purpose behind our careers.

In this episode, our guest is Arielle Miliambro, a Partner specializing in regulatory and transactional law within the Healthcare & Life Sciences departments. She assists clients with legal issues related to telehealth, data privacy, value-based care, and fraud compliance. She offers counsel on regulations like the Anti-Kickback Statute and prepares requests for OIG Advisory Opinions.

Arielle also guides stakeholders in telehealth and digital health models on fraud, corporate practice, and virtual care requirements. Additionally, she advises clients on data security and privacy issues, including HIPAA compliance and data breach response. She works with providers to develop value-based care and alternative payment models.

Her expertise extends to pharmacy clients, whom she advises on remote prescription processing, compliance, and licensing board matters. She also assists practitioners with in-office dispensing and scope of practice concerns. Furthermore, Arielle supports clients with corporate transactional matters, drafting various legal agreements and documents.

Telehealth Topics for Podcast

1. What is the difference between telehealth and telepharmacy
2. Pharmacy role in bigger picture of telehealth models
   • Considerations for kickbacks/fee splitting in telehealth models depending on pharmacy’s reimbursement
   • Pharmacists duty to validate script prior to dispensing
     • Telehealth “red flags”
     • Where does the line get drawn as to pharmacist’s obligations with respect to the actual patient encounter between prescriber/patient
3. Covid changes
   • State
     • Licensing flexibility for prescribers
     • Scope of practice of pharmacists
   • Federal
     • Telehealth reimbursement
     • DEA prescribing
       1. History / status of new rules related to CDS prescribing

1. Telehealth vs Telepharmacy Differences
   • Brief overview distinguishing the definitions of each:
     • Telehealth: Remote provision of clinical care
     • Telepharmacy: Remote provision of pharmacy services (e.g., offsite pharmacist doing DUR, offering patient counseling)
2. Changes in Telehealth During Covid
   • Federal and State Waivers
     • DEA waivers (current through 2025)
     • Physician licensing waivers by state (expired)
     • Modality flexibilities (mostly expired; some extended/made permanent depending on payor)
3. Pharmacist Obligations in Validating Telehealth Prescriptions
   • Pharmacist obligations/duties
   • BOP audits/investigations originating from BME
4. Maintaining Out-of-State Licenses for Telehealth Patients
5. DEA Updates with Proposed/New Final Rules
   
   

Guest - Arielle Miliambro

LinkedIn: Frier Levitt | LinkedIn

Instagram: N/A

Website: Frier Levitt | LinkedIn

YouTube: Frier Levitt - YouTube

Twitter/X: (2) Frier Levitt (@FrierLevitt) / X (twitter.com)

Host - Hillary Blackburn, PharmD, MBA

www.hillaryblackburn.com  

• https://www.linkedin.com/in/hillary-blackburn-67a92421/ 
• @talktoyourpharmacist for Instagram and Facebook

In this episode, Our guest is MARC RYAN, who has extensive leadership experience across the healthcare industry. Most recently, he was a founding executive and President of MedHOK (MHK, acquired by Hearst Health). He has launched and operated multiple health plans. Marc served in senior policy roles in state and federal government, including as state management secretary of Connecticut and helping build Medicare Part D’s relationship with state drug assistance programs in 2006. He created Connecticut’s Medicaid and children’s health managed care programs and its long-term care continuum. Marc is the author of The Healthcare Labyrinth: A Guide To Navigating Health Plans and Fixing American Health Insurance and the host of the Healthcare Labyrinth Podcast.

Topics covered:
(1) What are the trends in drug spending and the impact on all types of insurance products -- Medicare, Medicaid, commercial/employer -- cost trends for medical and retail

(2) What is driving the major increases in drug costs/spending?

(3) How are GLP-1s treated across various products? And will coverage change?

(4) American drug prices compared with others?  Can you discuss how we compare vs. other developed countries and why (more than twice -- in many cases 3, 4, and 5 times more -- impacts on employer, Medicare, etc. -- rising percentage of healthcare as well as employer) 

(5) Medicare drug price negotiations -- what it is and what has happened so far? where do you stand?
(6) A lot is occurring in plans on PA, formularies, benefit design, PBM reform -- a very hot topic -can you tell us more about this and what you predict? (7) Can you explain the traditional PBMs vs. transparent ones? FTC lawsuit against PBMs and drug supply channel issues

(8) There have been major changes to Part D and it is impacting Medicare Advantage and Part D -- what is happening for 2025 benefits as well as can you tell us a little on a study that questioned the value of Part D?

(9a) Medication Adherence in the Star program for MA and Part D plans -- key.  Can you tell us more here? 9(b) How could pharmacists in the community support medication adherence etc -- Will discuss trends from health plans about recognizing the best way to ensure medication reconciliation and adherence is teaming up with pharmacists. 

Guest - Marc Ryan

Host - Hillary Blackburn, PharmD, MBA

www.hillaryblackburn.com

• https://www.linkedin.com/in/hillary-blackburn-67a92421/ 
• @talktoyourpharmacist for Instagram and Facebook

In this episode, our guest is Laurie Lee Smith, who is the CEO of Laurie Lee Leadership and a seasoned executive coach with over three

decades of healthcare expertise, certified by the International Coaching Federation (ICF). Laurie’s international coaching and leadership engagements have spanned continents, including North America, the Middle East, Europe, and Asia, with a focus on enhancing the influence of healthcare leadership on a global scale. Her coaching philosophy is anchored in the cultivation of high-trust leaders who support teams capable of achieving peak interdependence. Laurie holds a Master of Science in Nursing Administration from the University of Mary and a Bachelor’s degree in Nursing from the University of Alaska, Anchorage. She also holds a Green Belt certification in LEAN Six Sigma, a certificate in Brain-Based Coaching, and Board Certification through the ANCC in advanced Nursing Administration. Laurie received her formal training in executive coaching at the Hudson Institute of Coaching and is currently working toward a PhD in Industrial/Organizational Psychology.

Main points:

1. Uncovering blind spots as a leader
2. Why we are resistant to change
3. How to improve social and emotional intelligence
4. How coaching can support growth as a leader

Guest - Laurie Lee Smith

LinkedIn: linkedin.com/in/laurie-lee-smith 

Website: www.laurieleeleadership.com

Host - Hillary Blackburn, PharmD, MBA

www.hillaryblackburn.com

• https://www.linkedin.com/in/hillary-blackburn-67a92421/ 
• @talktoyourpharmacist for Instagram and Facebook

In this episode, our guest, Tamar (Tay-mar) Thompson with us, the Head of Corporate Affairs at Alexion, AstraZeneca Rare Disease. With over 20 years of experience in healthcare, Tamar leads global corporate efforts in policy and advocacy. She recently has been showcasing Alexion’s new short film, Rare Connections in NMOSD where she underscores the need to raise awareness of NMOSD, a rare neurological disease, to help reduce the time to diagnosis and advance care. A dedicated advocate for health equity, Tamar continues to highlight the unmet needs of the rare disease community.

Topics

• Neuromyelitis optica spectrum disorder (NMOSD): diagnosis, prevalence/incidence, overview of symptoms, and why it’s so important to raise awareness of rare diseases
• Rare Connections in NMOSD and why Alexion created this first-of-its-kind short film
• What Alexion is doing to help improve equity and health outcomes for people living with rare diseases
• Unveiling Connections: The Story Behind Alexion’s Groundbreaking Film on NMOSD

• Bridging the Gap: Confronting the Diagnostic and Care Challenges in Rare Diseases

• Left Behind: Addressing Health Equity for the Rare Disease Community

• Global Voices: How Alexion Shapes Policy to Transform Rare Disease Care

• Driven by Purpose: Alexion’s Journey to Champion Rare Disease Advocacy

Guest - Tamar Thompson

LinkedIn:
- https://www.linkedin.com/company/alexion-pharmaceuticals/
- https://www.linkedin.com/in/tamarthompson/
Facebook: https://www.facebook.com/AlexionPharmaceuticalsInc/
Twitter/X: https://x.com/alexionpharma?lang=e
YouTube

• https://www.youtube.com/@alexionpharmaceuticalsinc.3357
• Rare Connections Film: https://youtu.be/cfnE7cxfY3s?si=zozSq2NZK8kb2i6k
• Rare Connections Film (Accessible Version): https://youtu.be/dwKpZQSZuZ0?si=77UN5QaRJNuM2rnm

Host - Hillary Blackburn, PharmD, MBA

www.hillaryblackburn.com

• https://www.linkedin.com/in/hillary-blackburn-67a92421/ 
• @talktoyourpharmacist for Instagram and Facebook

Talk to Your Pharmacist Podcast Interview - Danielle Vizcaino and Hillary Blackburn

Danielle Vizcaino, President and CEO of The Assistance Fund (TAF), discussed the organization's role in providing financial assistance to patients facing high medical out-of-pocket costs. TAF, founded in 2009, has helped over 190,000 people, including 40,070 in 2023, with nearly 100 disease-specific programs. Vizcaino highlighted the importance of patient referrals and the unique features of TAF, such as year-long assistance and no cap on annual assistance. She emphasized the need for continued support and awareness, especially for rare diseases like Duchenne muscular dystrophy and hypophosphatasia. Vizcaino also shared her journey from molecular biology to healthcare administration and her commitment to improving healthcare accessibility.

Introduction and Background of Danielle Vizcaino

• Hillary Blackburn welcomes Danielle Vizcaino and asks her to introduce herself and fill in any gaps in the intro.
• Danielle Vizcaino confirms her last name pronunciation and mentions the proposed items from Mark Meyer.
• Hillary Blackburn mentions she received the outline late due to being on vacation and will add it to her info.
• Danielle Vizcaino asks if she should be on camera; Hillary Blackburn mentions she hasn't done video yet but is open to it.

Overview of The Assistance Fund (TAF)

• Hillary Blackburn introduces Danielle Vizcaino as President and CEO of The Assistance Fund (TAF) and provides a brief overview of the organization.
• Danielle Vizcaino shares her passion for healthcare from a young age and her educational background in molecular biology, microbiology, MPH, and MBA.
• She details her career path, including roles in mycobacteriology, healthcare administration, and her transition to TAF in 2016.
• Danielle Vizcaino shares a personal discovery about being a carrier of a rare disease, which deepened her commitment to improving healthcare accessibility.

Details About The Assistance Fund (TAF)

• Danielle Vizcaino provides an introduction to TAF, explaining its role in helping patients and families with high medical out-of-pocket costs.
• She highlights TAF's 100 disease-specific programs and their impact, including helping over 190,000 people since 2009.
• Danielle Vizcaino mentions that in 2023, TAF helped 40,070 people, with many receiving year-after-year assistance due to genetic conditions.
• She discusses the importance of TAF's assistance, especially for insured patients with high-cost medical conditions.

Danielle Vizcaino's Career Path and TAF's Mission

• Hillary Blackburn asks Danielle Vizcaino about her path to becoming CEO of TAF and how she transitioned from molecular biology to nonprofit work.
• Danielle Vizcaino explains her initial interest in medicine and her shift towards healthcare administration and public health.
• She describes her experience with TAF, including building departments and infrastructure, and her eventual promotion to CEO in 2023.
• Danielle Vizcaino emphasizes the importance of TAF's mission and her gratitude for the opportunity to lead such a passionate team.

TAF's Role and Impact in the Healthcare Ecosystem

• Hillary Blackburn and Danielle Vizcaino discuss the importance of TAF in helping insured patients access necessary treatments.
• Danielle Vizcaino explains the difference between independent charitable patient assistance organizations and manufacturer patient assistance programs.
• She highlights TAF's unique features, such as offering assistance for the entire calendar year and the importance of patient referrals.
• Danielle Vizcaino provides details on how patients can qualify for TAF assistance, including eligibility requirements and the importance of checking the website for new programs.

Common Diseases and TAF's Support

• Hillary Blackburn asks about the most common diseases TAF supports, and Danielle Vizcaino mentions rare diseases, oncology, immunology, and respiratory conditions.
• Danielle Vizcaino shares specific examples of rare diseases TAF helps with, such as Duchenne muscular dystrophy and hypophosphatasia.
• She discusses the importance of TAF's support for patients with life-changing diseases and the role of donors in funding these efforts.
• Danielle Vizcaino encourages individuals to check TAF's website for new programs and to continue monitoring for new opportunities for assistance.

Founding Story and Funding of TAF

• Hillary Blackburn asks about TAF's founding story and how the organization supports patients across the country.
• Danielle Vizcaino explains that TAF was founded in 2009 by specialty pharmacists who recognized a need in the space.
• She highlights TAF's growth from a small organization to one with over 100 programs and close to 300 million in support.
• Danielle Vizcaino discusses TAF's individual philanthropy arm and the importance of corporate and individual funding for their programs.

Advice for Aspiring Leaders and Pharmacists

• Hillary Blackburn asks Danielle Vizcaino for advice for pharmacists and aspiring leaders in the healthcare field.
• Danielle Vizcaino emphasizes the importance of perseverance and commitment to making a difference in the community.
• She shares her own journey and the opportunities that arose from her passion and dedication to healthcare.
• Danielle Vizcaino encourages others to keep pushing forward and to look for opportunities to make an impact in the healthcare ecosystem.

Conclusion and Closing Remarks

• Hillary Blackburn thanks Danielle Vizcaino for sharing more about TAF and for being a guest on the podcast.
• Danielle Vizcaino expresses her appreciation for the opportunity to share TAF's story and mission.

Guest - Danielle Vizcaino 

Facebook: https://www.facebook.com/AssistanceFund 

Instagram: https://www.instagram.com/theassistancefund/ 

LinkedIn: https://www.linkedin.com/company/the-assistance-fund/ 

Threads: https://www.threads.net/@theassistancefund 

YouTube: https://www.youtube.com/channel/UC-rJY98PFtKyMCBpdYpzDEQ 

Website: https://tafcares.org/ 

Host - Hillary Blackburn, PharmD, MBA

www.hillaryblackburn.com

• https://www.linkedin.com/in/hillary-blackburn-67a92421/ <...

In this episode, our guest is Dr. Brian Clyne who is a Professor of Emergency Medicine at the Alpert Medical School of Brown University

where he has served in numerous clinical, educational, and administrative leadership roles over the past 20 years. As Vice Chair for Education at ACT Leadership, Dr. Clyne develops and supports programs across the continuum of learners from undergraduates to faculty. In addition to medical education, Dr. Clyne’s areas of interest include career development and physician leadership. He founded and directed Leadership in Healthcare, a master’s level course for Alpert Medical School students. He is a

graduate of the Brown University Executive Master’s in Healthcare Leadership program and the ACT

Leadership and Performance Coaching Certificate program. His coaching practice is focused on mid-career healthcare professionals seeking to expand their leadership capabilities to make a lasting impact.

Talk to Your Pharmacist Podcast Interview - Dr. Brian Cyne and Hillary Blackburn

Hillary Blackburn and Brian Clyne discussed their experiences in healthcare leadership and career development, emphasizing the importance of transferable knowledge and skills, navigating career transitions, and addressing burnout. They also discussed the role of coaching in healthcare leadership development, highlighting the need for practical leadership skills beyond clinical expertise and the importance of selecting the right coach with industry background or experience in healthcare-related fields. Both speakers emphasized the transformative impact of coaching on personal and professional growth.

Leadership and healthcare with Dr. Brian Clyne.

• Hillary Blackburn discusses work-life balance as a healthcare leader with two young children.
• Hillary Blackburn interviews Dr. Brian Clyne on The Talk to Your Pharmacist podcast.

Leadership development and coaching in healthcare.

• Brian Clyne discusses his background in psychology and medicine, focusing on medical education and leadership development.
• Brian Clyne: Read Harvard Business Review, Good to Great, and David Rock's Quiet Leadership.
• Hillary Blackburn: Also read leadership books, including Good to Great and David Rock's Quiet Leadership.

Leadership development and coaching.

• Hillary Blackburn and Brian Clyne discuss leadership development and coaching.
• Brian Clyne learned coaching skills through Act Leadership, a training organization.
• Brian Clyne shares his journey from directive to curious leadership, empowering others to find solutions.
• Hillary Blackburn asks about what sets Act program apart, offering guidance for choosing a coach.
• Brian Clyne emphasizes the importance of finding a coach with relevant industry experience.
• Clyne suggests asking a coach about their methodology and experience with your specific challenge.

Coaching in healthcare, burnout, leadership, and career development.

• Hillary Blackburn and Brian Clyne discuss coaching in healthcare, common triggers, and leadership skills.
• Brian Clyne coaches newly transitioned leaders on goal setting, prioritization, and time management.
• He also helps individuals experiencing burnout by exploring their core values and setting boundaries.
• Burnout and career transitions are common challenges in healthcare.

Burnout and career development in healthcare.

• Brian Clyne: Realize it's a marathon, not a sprint, and don't expect it to go according to plan.
• Brian Clyne: Emergency medicine has highest rates of burnout, and lack of control, uncertainty lead to it.
• Brian Clyne: Importance of networking, mentorship, and focus in career success.
• Hillary Blackburn: Struggling with imposter syndrome and seeking guidance from peers.
• Hillary Blackburn and Brian Clyne discuss career development and burnout in the pharmacy industry.
• Brian Clyne shares resources for coaches and pharmacists, including ACT Leadership and Brown University.

Guest -  Brian Clyne, MD

Host - Hillary Blackburn, PharmD, MBA

www.hillaryblackburn.com

• https://www.linkedin.com/in/hillary-blackburn-67a92421/ 
• @talktoyourpharmacist for Instagram and Facebook

In this episode, Our guest, Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA is a pharmacist-attorney in Frier Levitt’s Life Sciences Department. Her practice focuses on healthcare law; Food, Drug Cosmetic law; pharmacy law and regulatory issues; PBM issues; as well as pharmaceutical and medical device intellectual property including trademark, copyright, trade secret and all aspects of patent law (due diligence, prosecution, opinion work, litigation, and transactional matters). Dr. Rumore has over 15 years of law firm experience in the area of Food, Drug & Cosmetic Law and pharmaceutical intellectual property, counseling on early market opportunities for pharmaceutical clients particularly in the area of ANDA and 510K applications and all facets of Paragraph IV litigation.

Dr. Rumore has also worked in Drug Regulatory Affairs in the pharmaceutical industry and hospital pharmacy, both at the Director level. She taught Pharmacy Law and Drug Regulatory Affairs at Arnold & Marie Schwartz College of Pharmacy and Touro College of Pharmacy for close to 20 years and currently teaches Food, Drug & Cosmetic Law at Maurice A. Deane School of Law at Hofstra University.

She is a frequent lecturer and has over 200 publications and presentations. Additionally, Dr. Rumore is a Fellow and former Trustee of the American Pharmacists Association, a former Board member of the American Society for Pharmacy Law and the Accreditation Council for Pharmacy Education and is a three-time recipient of the Larry Simonsmeier Legal Writing Award.

This in-depth discussion on the current regulatory landscape for compounding pharmacies will look at:

• Current Regulatory Environment for 503A and 503B Compounding
• State Laws and State Board of Pharmacy 2023/2024
• Important Regulatory Considerations in the 503B to 503A Compounding Model for Community Pharmacies
• 506e Shortages and Beyond
• USP 797/795 Six Months Later

Guest - Martha Rumore Senior Counsel

[email protected]

646.970.3226

Host - Hillary Blackburn, PharmD, MBA

www.hillaryblackburn.com  

• https://www.linkedin.com/in/hillary-blackburn-67a92421/ 
• @talktoyourpharmacist for Instagram and Facebook

@HillBlackburn Twitter

In this episode, our guest is Kyle Turner, who is an Associate Professor (Clinical) at the University of Utah College of Pharmacy and a clinical pharmacist at the Midvale Clinic. He earned his PharmD degree at the University of Utah College of Pharmacy and then completed the Pharmaceutical Care Leadership Residency at the University of Minnesota. Currently, he is directing the Utah Pharmacist Payer Provider Patient (UP4) Alliance dedicated to creating partnership between health care stakeholders to improve outcomes, lower cost and improve the patient experience. His scholarly and teaching interests center on fostering leadership, interprofessional education, team-based practice development, and health care innovation.

He is also a consultant and national trainer for Intend Health Strategies, a non-profit dedicated to leadership development in the health care industry. Through Intend, Kyle shares the Relational Leadership framework with a diverse set of professionals across stages of training and practice with the goal of enhancing interprofessional teams and ultimately delivering better care. He and his wife have three active children and enjoy fun, faith and family together in Salt Lake City, Utah. 

Main Points

1. Background from pharmacy school to leadership development. Story of going to Boston for first Intend Health Summit and lessons learned. This led to staying involved and going to U of Minnesota for a very specific type of residency. [5 min]
2. What is Intend Health Strategies and Relational Leadership?
3. The problems we are trying to tackle:
   1. Most people don’t get any or enough leadership/teaming/relational training in professional programs. Get’s somewhat better in residency or through professional orgs but that can be limited. Need to boost our efforts. 
   2. Humans are wired for community and react to the signals sent by others – the signals we send become essential in building positive workplace cultures 
   3. Too many members of healthcare teams do not feel seen, heard, or valued
   4. There is a misalignment of workstyles, a lack of understanding of each other's work
   5. We do not universally have the tools and confidence to manage tension and conflict, which consistently arise when problems above are present
4. Solution & Application
   1. Practical and easy skills to incorporate into day-to-day operations
   2. Especially useful for those (like pharmacists) who may not intuitively feel like they can connect and build relationships 
   3. Examples of content (if interested) and practical tips for application

Guest: Kyle Turner, PharmD 

• https://www.intendhealth.org/
• https://pharmacy.utah.edu/pharmacotherapy/faculty/turner 
• https://www.linkedin.com/in/kyle-turner-21bab06b/
• https://www.linkedin.com/company/intendhealth/ 

Host - Hillary Blackburn, PharmD, MBA

• www.hillaryblackburn.com  
• https://www.linkedin.com/in/hillary-blackburn-67a92421/ 
• @talktoyourpharmacist for Instagram and Facebook